To further investigate the relationship between EN2 and drug resistance, IC50 experiments revealed that GBM cells with the silence of EN2 exhibited reduced resistance to TMZ when treated with various concentrations of TMZ (Figure 7B). This evidence concerns the gene EN2 and glioblastoma.